Shigeo Ichihashi/LinkedIn
Oct 18, 2025, 05:13
The CLARIFY IMA Study From Shigeo Ichihashi and Colleagues was Recently Published!
Vascular News shared Shigeo Ichihashi’s and colleagues latest study on LinkedIn:
“Results from a multicentre randomised controlled trial indicate that pre-emptive inferior mesenteric artery (IMA) embolisation during endovascular aneurysm repair (EVAR) does not significantly reduce aneurysm sac volume or rates of type II endoleak.
The CLARIFY IMA study from Shigeo Ichihashi (Nara Medical University, Nara, Japan) and colleagues was recently published in the European Journal of Vascular and Endovascular Surgery (EJVES) and presented at the 39th European Society for Vascular Surgery annual meeting (23–26 September, Istanbul, Türkiye).”

Read more here.
Stay updated about IMA latest news with Hemostasis Today.
-
Aug 11, 2026, 15:42Iva Pruner: Hemostasis, Thrombosis, and a Little Death Metal
-
Aug 11, 2026, 15:25Bradley Maron։ The AI Revolution in Cardiovascular Drug Development
-
Aug 11, 2026, 15:10Jared Rice: When a Negative DAT Doesn’t Mean the Alloimmune Risk Is Gone
-
Aug 11, 2026, 14:58Manuel De Jesus: Validating the Future of Point-of-Care Anemia Monitoring
-
Aug 11, 2026, 14:30Bharat Moyal: The New KDIGO 2026 Approach to Anemia in CKD
-
Aug 11, 2026, 14:16Rayan Ahmed: Master Blood Films and Pathology Online
-
Aug 11, 2026, 13:53Steven Lubega: Why Are Healthy Newborns Born Poorly Equipped To Stop Bleeding?
-
Aug 11, 2026, 13:47Why Stroke Risk Changes During Pregnancy – International Journal of Stroke
-
Aug 11, 2026, 13:43Moyahabo Julius Rampya: Shaping the Future of Stroke Care in Africa